The Goldman Sachs people who aren't waiting for bonuses
There's never a good time to leave, but there are always worse ones.
Source: efinancialcareers.com
Michael Leuchten News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Michael Leuchten. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Michael Leuchten Today - Breaking & Trending Today
Weight-Loss Giant Novo's Fat Valuation Leaves No Room For Error
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
Source: zerohedge.com
Ozempic Maker Novo Rises After First Stock Split in a Decade
(Bloomberg) -- Novo Nordisk A/S shares fell on Wednesday in the first trading session following a split aimed at increasing the liquidity of the Danish drugmaker’s soaring stock.Most Read from BloombergLuxury Cruise Ship Full of Australians Stuck in Greenland ArcticiPhone Pro’s Titanium Finish Stands Out in First Look at DeviceChina Flags ‘Security Incidents’ With Apple’s iPhonesApple’s iPhone 15 Debut Includes Higher Price on Top ModelAT&T, T-Mobile Offer Free iPhone 15 in Lure for New Subscrib
Source: yahoo.com
ASTRAZENECA : UBS gives a Buy rating -Today at 07:25 am
In his latest research note, analyst Michael Leuchten confirms his positive recommendation. The broker UBS is keeping its Buy rating. The target price is unchanged and still at GBX 13000.
Source: marketscreener.com
ROCHE HOLDINGS AG : UBS gives a Neutral rating -Today at 08:13 am
Analyst Michael Leuchten from UBS research gives the stock a Neutral rating. The target price remains set at CHF 280.
Source: marketscreener.com